214 related articles for article (PubMed ID: 25791210)
1. Getting to the core of protein pharmaceuticals--Comprehensive structure analysis by mass spectrometry.
Leurs U; Mistarz UH; Rand KD
Eur J Pharm Biopharm; 2015 Jun; 93():95-109. PubMed ID: 25791210
[TBL] [Abstract][Full Text] [Related]
2. [Utilization of Hydrogen/Deuterium Exchange in Biopharmaceutical Industry].
Coufalová D; Vojtěšek B; Hernychova L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):59-63. PubMed ID: 27846722
[TBL] [Abstract][Full Text] [Related]
3. Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.
Huang RY; Chen G
Anal Bioanal Chem; 2014 Oct; 406(26):6541-58. PubMed ID: 24948090
[TBL] [Abstract][Full Text] [Related]
4. Measuring the hydrogen/deuterium exchange of proteins at high spatial resolution by mass spectrometry: overcoming gas-phase hydrogen/deuterium scrambling.
Rand KD; Zehl M; Jørgensen TJ
Acc Chem Res; 2014 Oct; 47(10):3018-27. PubMed ID: 25171396
[TBL] [Abstract][Full Text] [Related]
5. Top-down mass spectrometry and hydrogen/deuterium exchange for comprehensive structural characterization of interferons: implications for biosimilars.
Pan J; Borchers CH
Proteomics; 2014 May; 14(10):1249-58. PubMed ID: 24574185
[TBL] [Abstract][Full Text] [Related]
6. Technical decision making with higher order structure data: utilization of differential scanning calorimetry to elucidate critical protein structural changes resulting from oxidation.
Arthur KK; Dinh N; Gabrielson JP
J Pharm Sci; 2015 Apr; 104(4):1548-54. PubMed ID: 25561411
[TBL] [Abstract][Full Text] [Related]
7. Structural mass spectrometry in biologics discovery: advances and future trends.
Mo J; Tymiak AA; Chen G
Drug Discov Today; 2012 Dec; 17(23-24):1323-30. PubMed ID: 22819924
[TBL] [Abstract][Full Text] [Related]
8. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.
Houde D; Berkowitz SA; Engen JR
J Pharm Sci; 2011 Jun; 100(6):2071-86. PubMed ID: 21491437
[TBL] [Abstract][Full Text] [Related]
9. Analytical lessons learned from selected therapeutic protein drug comparability studies.
Federici M; Lubiniecki A; Manikwar P; Volkin DB
Biologicals; 2013 May; 41(3):131-47. PubMed ID: 23146362
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review.
Deng B; Lento C; Wilson DJ
Anal Chim Acta; 2016 Oct; 940():8-20. PubMed ID: 27662755
[TBL] [Abstract][Full Text] [Related]
11. Mapping the Interactions of Selective Biochemical Probes of Antibody Conformation by Hydrogen-Deuterium Exchange Mass Spectrometry.
Leurs U; Beck H; Bonnington L; Lindner I; Pol E; Rand K
Chembiochem; 2017 Jun; 18(11):1016-1021. PubMed ID: 28346764
[TBL] [Abstract][Full Text] [Related]
12. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
Srebalus Barnes CA; Lim A
Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
[TBL] [Abstract][Full Text] [Related]
13. Probing protein interactions with hydrogen/deuterium exchange and mass spectrometry-a review.
Percy AJ; Rey M; Burns KM; Schriemer DC
Anal Chim Acta; 2012 Apr; 721():7-21. PubMed ID: 22405295
[TBL] [Abstract][Full Text] [Related]
14. The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis.
Thompson NJ; Rosati S; Rose RJ; Heck AJ
Chem Commun (Camb); 2013 Jan; 49(6):538-48. PubMed ID: 23183499
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry for structural characterization of therapeutic antibodies.
Zhang Z; Pan H; Chen X
Mass Spectrom Rev; 2009; 28(1):147-76. PubMed ID: 18720354
[TBL] [Abstract][Full Text] [Related]
16. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.
Chen G; Warrack BM; Goodenough AK; Wei H; Wang-Iverson DB; Tymiak AA
Drug Discov Today; 2011 Jan; 16(1-2):58-64. PubMed ID: 21093608
[TBL] [Abstract][Full Text] [Related]
17. Subzero temperature chromatography and top-down mass spectrometry for protein higher-order structure characterization: method validation and application to therapeutic antibodies.
Pan J; Zhang S; Parker CE; Borchers CH
J Am Chem Soc; 2014 Sep; 136(37):13065-71. PubMed ID: 25152011
[TBL] [Abstract][Full Text] [Related]
18. Antibody structure, instability, and formulation.
Wang W; Singh S; Zeng DL; King K; Nema S
J Pharm Sci; 2007 Jan; 96(1):1-26. PubMed ID: 16998873
[TBL] [Abstract][Full Text] [Related]
19. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.
Katsila T; Siskos AP; Tamvakopoulos C
Mass Spectrom Rev; 2012; 31(1):110-33. PubMed ID: 21698655
[TBL] [Abstract][Full Text] [Related]
20. Conformational analysis of g protein-coupled receptor signaling by hydrogen/deuterium exchange mass spectrometry.
Li S; Lee SY; Chung KY
Methods Enzymol; 2015; 557():261-78. PubMed ID: 25950969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
